Pharmapac (U.K.) Limited
03201556
Healthy
- No accounts filed in last 18 months (-5)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
30/06/2024
full
Next accounts due
30/06/2026
Confirmation statement
Last: 21/05/2025
Due 04/06/2026
Industry
Officers
Geoffrey Elliott
director · Since 19/12/2014
British
John James Pugh
director · Since 27/03/2018
British
Former
Suzanne Brewer
nominee secretary · Resigned 21/05/1996
Clive Brown
secretary · Resigned 31/05/2009
Geoffrey Elliot
secretary · Resigned 10/06/2008
David Albert Robinson
secretary · Resigned 27/03/2008
Steven Gary Scott
secretary · Resigned 01/09/2015
Kevin Brewer
nominee director · Resigned 21/05/1996
Geoffrey Elliot
director · Resigned 10/06/2008
Keith Elliott
director · Resigned 01/06/2016
Mark Elliott
director · Resigned 01/06/2016
Harold Alexander Ennis
director · Resigned 10/06/2008
Mark Ennis
director · Resigned 10/06/2008
Stephen Patrick Penrose
director · Resigned 27/03/2008
David Albert Robinson
director · Resigned 27/03/2008
Ian Paul Robinson
director · Resigned 10/03/2017
Andrew Michael Sampson
director · Resigned 10/03/2020
Andrew John Ward
director · Resigned 19/12/2014
Paul John White
director · Resigned 26/06/2000
CompanyRankvs 105+ SIC 21100 peers79
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going co
Key FinancialsYear ending 30/06/2024
Turnover
£12.2M
Annual revenue
Net Worth
£8.1M
Balance sheet strength
Cash
£447k
Cash in the bank
Profit Before Tax
£541k
Bottom line earnings
Net Current Assets
£4.3M
Working capital
Current Assets
£7.1M
Current Liabilities
£2.8M
Fixed Assets
£5.8M
Debtors
£5.5M
Cost of Sales
£8.4M
Gross Profit
£3.7M
Admin Expenses
£3.2M
Operating Profit
£546k
Profit After Tax
£219k
Tax at Year End
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2024 | 2.50 |
Derived from filed accounts. Not audited figures.